623 related articles for article (PubMed ID: 2421645)
41. [Interferon therapy in malignant melanoma].
Stadler R; Garbe C
Z Hautkr; 1990 May; 65(5):504-7. PubMed ID: 1696048
[TBL] [Abstract][Full Text] [Related]
42. [Clinical trials of interferon-beta (MR-21) in the treatment of malignant tumors of the skin].
Kukita A
Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):977-86. PubMed ID: 3320228
[No Abstract] [Full Text] [Related]
43. Response of subcutaneous and cutaneous metastases of malignant melanoma to combined cytostatic plus interferon therapy.
Hahka-Kemppinen M; Muhonen T; Virolainen M; Jekunen A; Asko-Seljavaara S; Pyrhönen S
Br J Dermatol; 1995 Jun; 132(6):973-7. PubMed ID: 7544996
[TBL] [Abstract][Full Text] [Related]
44. Postoperative DAV-IFN-β therapy does not improve survival rates of stage II and stage III melanoma patients significantly.
Matsumoto T; Yokota K; Sawada M; Sakakibara A; Shibata S; Yasue S; Tomita Y; Yatsuya H; Akiyama M
J Eur Acad Dermatol Venereol; 2013 Dec; 27(12):1514-20. PubMed ID: 23198869
[TBL] [Abstract][Full Text] [Related]
45. Sequential treatment with interferon and chemotherapy of metastatic malignant melanoma. Total remission of cutaneous and visceral metastasis, but not of cerebral metastasis.
Sulis E; Floris C; Chessa A; Desogus A; Muggiano A; Tedde A; Turno R
Tumori; 1987 Feb; 73(1):55-8. PubMed ID: 3824533
[TBL] [Abstract][Full Text] [Related]
46. [Adjuvant therapy with recombinant interferon alfa-2a in metastasized malignant melanoma].
Elsässer-Beile U; Garbe C; Stadler R; Drews H; Schöpf E
Hautarzt; 1989 May; 40(5):266-70. PubMed ID: 2737901
[TBL] [Abstract][Full Text] [Related]
47. [The usefulness of neo- and adjuvant therapy in the treatment of cutaneous melanoma].
Dzhabarov FR; Rozenko LIa; Pozdniakova VV; Nepomniashchaia EM
Vopr Onkol; 2011; 57(4):521-4. PubMed ID: 22191247
[TBL] [Abstract][Full Text] [Related]
48. [Comment on the contribution by C. Garbe et al.: Combination of interferon-alpha with cytostatic drugs: promising therapeutic approach in metastatic melanoma].
Kleeberg UR; Kölmel KF
Hautarzt; 1992 Nov; 43(11):737-8. PubMed ID: 1468937
[No Abstract] [Full Text] [Related]
49. [Adjuvant chemotherapy of malignant melanoma of the female genital organs].
Inoue S; Shibata S; Tohya T; Munemura M; Fujisaki S; Maeyama M
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jan; 38(1):135-8. PubMed ID: 3456398
[No Abstract] [Full Text] [Related]
50. [Metastatic malignant melanoma of the urinary bladder: a case report].
Nohara T; Sakai A; Fuse H; Imamura Y
Nihon Hinyokika Gakkai Zasshi; 2009 Nov; 100(7):707-11. PubMed ID: 19999137
[TBL] [Abstract][Full Text] [Related]
51. Two cases of malignant melanoma of the toe developed skin ulcers following local injection of natural beta-interferon.
Kurashige Y; Irisawa R; Abe N; Saito M; Tsuboi R
J Dermatol; 2012 Dec; 39(12):1037-8. PubMed ID: 22758215
[No Abstract] [Full Text] [Related]
52. The CD4+/CD8+ ratio as a prognostic factor in patients with metastatic melanoma receiving chemoimmunotherapy.
Hernberg M; Muhonen T; Turunen JP; Hahka-Kemppinen M; Pyrhönen S
J Clin Oncol; 1996 May; 14(5):1690-6. PubMed ID: 8622089
[TBL] [Abstract][Full Text] [Related]
53. Malignant melanoma: prognostic factors and therapeutic results.
DeVita VT; Fisher RI
W V Med J; 1977 Aug; 73(8):167-72. PubMed ID: 268079
[No Abstract] [Full Text] [Related]
54. Systemic therapy of advanced metastatic malignant melanoma with a combination of fibroblast interferon-beta and recombinant interferon-gamma.
Kowalzick L; Weyer U; Lange P; Breitbart EW
Dermatologica; 1990; 181(4):298-303. PubMed ID: 2127402
[TBL] [Abstract][Full Text] [Related]
55. A randomized trial of adjuvant chemotherapy and immunotherapy in Stage I and Stage II cutaneous melanoma. An interim report.
Sterchi JM; Wells HB; Case LD; Spurr CL; White DR; Richards F; Muss HB; Jackson DV; Stuart JJ; Cooper MR
Cancer; 1985 Feb; 55(4):707-12. PubMed ID: 3967167
[TBL] [Abstract][Full Text] [Related]
56. Intralesional interferon-alpha therapy in advanced malignant melanoma.
von Wussow P; Block B; Hartmann F; Deicher H
Cancer; 1988 Mar; 61(6):1071-4. PubMed ID: 3342367
[TBL] [Abstract][Full Text] [Related]
57. Statistical survey from 1982 to 1991 of 49 patients with malignant melanocytic tumors.
Ueda E; Kishimoto S; Yasuno H
J Dermatol; 1995 Jul; 22(7):467-74. PubMed ID: 7560435
[TBL] [Abstract][Full Text] [Related]
58. Treatment of advanced malignant melanoma with interferon alpha and etretinate.
Rustin GJ; Dische S; de Garis ST; Nelstrop A
Eur J Cancer Clin Oncol; 1988 Apr; 24(4):783-4. PubMed ID: 3383979
[TBL] [Abstract][Full Text] [Related]
59. Immunohistological analysis of in-transit metastasis in a patient with advanced melanoma treated with combination therapy of cytosine guanine dinucleotide oligodeoxynucleotide, dacarbazine and beta-interferon: a case report.
Ozawa A; Nomiyama T; Nakai N; Hartmann G; Takenaka H; Kishimoto S; Katoh N
J Dermatol; 2012 Dec; 39(12):1035-7. PubMed ID: 22390792
[No Abstract] [Full Text] [Related]
60. [Synergistic antitumor effect of human interferon-beta and hyperthermia on the growth of human melanoma cells implanted in nude mice].
Nakagawa H; Yamada K
Nihon Hifuka Gakkai Zasshi; 1985 Sep; 95(10):1091-4. PubMed ID: 4079077
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
